AU2225199A - Human suppressor trna oligonucleotides and methods of use for same - Google Patents

Human suppressor trna oligonucleotides and methods of use for same

Info

Publication number
AU2225199A
AU2225199A AU22251/99A AU2225199A AU2225199A AU 2225199 A AU2225199 A AU 2225199A AU 22251/99 A AU22251/99 A AU 22251/99A AU 2225199 A AU2225199 A AU 2225199A AU 2225199 A AU2225199 A AU 2225199A
Authority
AU
Australia
Prior art keywords
same
suppressor trna
oligonucleotides
methods
human suppressor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22251/99A
Other languages
English (en)
Inventor
Charles J. Link Jr.
Rekha G. Panchal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Gene Therapy Research Institute
Original Assignee
Human Gene Therapy Res Institute
Human Gene Therapy Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Gene Therapy Res Institute, Human Gene Therapy Research Institute filed Critical Human Gene Therapy Res Institute
Publication of AU2225199A publication Critical patent/AU2225199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04B—TRANSMISSION
    • H04B10/00—Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
    • H04B10/25—Arrangements specific to fibre transmission
    • H04B10/2589—Bidirectional transmission
    • H04B10/25891—Transmission components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Electromagnetism (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AU22251/99A 1998-01-14 1999-01-13 Human suppressor trna oligonucleotides and methods of use for same Abandoned AU2225199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7141698P 1998-01-14 1998-01-14
US60071416 1998-01-14
PCT/US1999/000717 WO1999036519A1 (en) 1998-01-14 1999-01-13 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME

Publications (1)

Publication Number Publication Date
AU2225199A true AU2225199A (en) 1999-08-02

Family

ID=22101183

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22251/99A Abandoned AU2225199A (en) 1998-01-14 1999-01-13 Human suppressor trna oligonucleotides and methods of use for same

Country Status (8)

Country Link
US (2) US6309830B1 (cg-RX-API-DMAC7.html)
EP (1) EP1045902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002508959A (cg-RX-API-DMAC7.html)
AT (1) ATE299179T1 (cg-RX-API-DMAC7.html)
AU (1) AU2225199A (cg-RX-API-DMAC7.html)
CA (1) CA2318374C (cg-RX-API-DMAC7.html)
DE (1) DE69926052T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999036519A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法
KR20010079671A (ko) * 1998-08-20 2001-08-22 스티븐 에이. 서윈. 엠.디. 재조합 유전자 생성물을 생성시키는 동안 세포독성을조절하는 억제 tRNA의 용도
WO2003033521A1 (en) * 2001-10-16 2003-04-24 Massachusetts Institute Of Technology Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
US20050261210A1 (en) * 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
WO2005086768A2 (en) * 2004-03-11 2005-09-22 Albert Einstein College Of Medicine Of Yeshiva University Enhanced production of functional proteins from defective genes
WO2008064304A2 (en) * 2006-11-22 2008-05-29 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
ATE553764T1 (de) * 2007-09-14 2012-05-15 Trana Discovery Zusammensetzungen und verfahren zur identifizierung von inhibitoren einer retrovirusinfektion
CA2776044A1 (en) * 2008-09-29 2010-04-01 Trana Discovery, Inc. Screening methods for identifying specific staphylococcus aureus inhibitors
CN107177592B (zh) * 2016-03-10 2021-03-30 北京大学 抑制性tRNA通读提前终止密码子疾病中的截短蛋白
CN110612353A (zh) * 2017-03-03 2019-12-24 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
MX2020004587A (es) * 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022528696A (ja) * 2019-04-11 2022-06-15 アークタラス テラピュウティクス、インク アンチコドンループを延長した合成転移rna
LU101182B1 (en) * 2019-04-11 2020-10-12 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US11827880B2 (en) 2019-12-02 2023-11-28 Shape Therapeutics Inc. Therapeutic editing
BR112022020780A2 (pt) 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
WO2022125531A1 (en) * 2020-12-07 2022-06-16 President And Fellows Of Harvard College Methods for making and using genomically recoded cells
AU2023212951A1 (en) * 2022-01-25 2024-08-29 Hc Bioscience, Inc. Universal suppressor trnas and uses thereof
USD1118947S1 (en) * 2024-05-29 2026-03-17 Shock Doctor, Inc. Knee brace
USD1121161S1 (en) * 2024-05-29 2026-03-31 Shock Doctor, Inc. Knee brace

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687737A (en) 1982-11-12 1987-08-18 Massachusetts Institute Of Technology Mammalian suppressor genes
US4970155A (en) * 1983-03-07 1990-11-13 Abbott Laboratories HSV helper virus independent vector
US6111095A (en) * 1995-06-07 2000-08-29 Merck & Co., Inc. Capped synthetic RNA, analogs, and aptamers
JP2002508959A (ja) * 1998-01-14 2002-03-26 ヒューマン ジーン セラピー リサーチ インスティテュート ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法

Also Published As

Publication number Publication date
CA2318374A1 (en) 1999-07-22
US7029665B2 (en) 2006-04-18
DE69926052T2 (de) 2006-04-27
EP1045902A1 (en) 2000-10-25
US20020156042A1 (en) 2002-10-24
CA2318374C (en) 2012-09-04
JP2002508959A (ja) 2002-03-26
DE69926052D1 (de) 2005-08-11
WO1999036519A1 (en) 1999-07-22
EP1045902B1 (en) 2005-07-06
ATE299179T1 (de) 2005-07-15
US6309830B1 (en) 2001-10-30
HK1033955A1 (en) 2001-10-05

Similar Documents

Publication Publication Date Title
ATE299179T1 (de) Menschliche suppressor trna oligonukleotide und verfahren für deren verwendung
WO2003013437A3 (en) Compositions and methods for the prevention and treatment of huntington's disease
FR12C0004I1 (cg-RX-API-DMAC7.html)
ZA984463B (en) Fused dihydropyrans
AP1411A (en) Pyrrolo[2,3d] pyrimidine compositions and their use.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
PL324285A1 (en) Pyrollepyrimidines and methods of obtaining them
DE69525736D1 (de) Oligonukleotid und kanzerostatisches mittel das dieses als aktiven inhaltstoff enthält
IL157364A0 (en) Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1
ZA961484B (en) Dna molecules preparation and use in gene therapy
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
PL333429A1 (en) Benzonaphtyridines useful in particular in treating bronchial diseases
SG166672A1 (en) Methods of down regulating target gene expression in vivo by introduction of interfering rna
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
EP1007638A4 (en) KCNQ POTASSIUM CHANNELS AND METHOD FOR CHANGING THEM
AU2180501A (en) Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
AU1278600A (en) Novel therapeutic application of nicergoline
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase